Gemcitabine-vitamin E conjugates: Synthesis, characterization, entrapment into nanoemulsions, and in-vitro deamination and antitumor activity
Authors:
- 1 August 2017
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 528 (1-2) , 463-470
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences of the National Institutes of Health (P20GM103424)
This publication has 20 references indexed in Scilit:
- PEGylated γ-tocotrienol isomer of vitamin E: Synthesis, characterization, in vitro cytotoxicity, and oral bioavailabilityEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- Lysosomal Delivery of a Lipophilic Gemcitabine Prodrug Using Novel Acid-Sensitive Micelles Improved Its Antitumor ActivityBioconjugate Chemistry, 2012
- Induction of DNA Damage and Caspase-Independent Programmed Cell Death by Vitamin ENutrition and Cancer, 2012
- EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activityJournal of Controlled Release, 2012
- Identification of an emulsifier and conditions for preparing stable nanoemulsions containing the antioxidant astaxanthinInternational Journal of Cosmetic Science, 2011
- In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticlesInternational Journal of Pharmaceutics, 2011
- γ-Tocotrienol Inhibits Pancreatic Tumors and Sensitizes Them to Gemcitabine Treatment by Modulating the Inflammatory MicroenvironmentCancer Research, 2010
- Phenotype and Genotype of Pancreatic Cancer Cell LinesPancreas, 2010
- Gemcitabine chemoresistance in pancreatic cancer: Molecular mechanisms and potential solutionsScandinavian Journal of Gastroenterology, 2009
- Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugsJournal of Controlled Release, 2004